Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Total Current Liabilities ₹1,863 Cr₹2,623 Cr₹1,353 Cr₹1,251 Cr₹1,024 Cr

What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Current Liabilities ratio of MANKIND PHARMA is ₹1,863 Cr based on Mar2023 Consolidated results.
Year Total Current Liabilities
Mar2023₹1,863 Cr
Mar2022₹2,623 Cr
Mar2021₹1,353 Cr
Mar2020₹1,251 Cr
Mar2019₹1,024 Cr

How is Total Current Liabilities of MANKIND PHARMA Trending?

Years Total Current Liabilities % Change
Mar2023 ₹1,863 Cr
-28.98
Mar2022 ₹2,623 Cr
93.84
Mar2021 ₹1,353 Cr
8.21
Mar2020 ₹1,251 Cr
22.13
Mar2019 ₹1,024 Cr -

Compare Total Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,865.6 Cr -6.5% -7.6% 57% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr 2% -0.3% 59.8% Stock Analytics
CIPLA ₹112,990.0 Cr 6% 2.8% 50.4% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 2.6% 7.9% 94.3% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 3.7% 5.8% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1.3% -2.8% 31.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.5%

-7.6%

57%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses